Overview
New York, NY – August 20, 2026 – The Global Blood Collection Devices Market Size is expected to be worth around US$ 15.88 Billion by 2034, from US$ 7.85 Billion in 2024, growing at a CAGR of 7.3% during the forecast period from 2025 to 2034. North America held a dominant market position, capturing more than a 35.6% share and holds US$ 2.79 billion market value for the year.
The Blood Collection Devices Market is growing steadily due to increasing diagnostic procedures, rising chronic disease prevalence, and advancements in safe blood sampling technologies. Blood collection devices such as needles, blood collection tubes, lancets, syringes, and vacuum blood collection systems are widely used in hospitals, diagnostic laboratories, blood banks, and research centers for accurate and efficient sample collection.
The rising burden of chronic diseases is a major factor driving demand for blood collection products. According to the International Diabetes Federation (IDF), around 537 million adults worldwide were living with diabetes in 2021, with the number expected to reach 643 million by 2030 and 783 million by 2045.
The increasing need for glucose monitoring and routine blood testing is supporting market expansion. Cancer diagnostics are also contributing to demand growth. The World Health Organization (WHO) reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, increasing the requirement for blood-based diagnostic tests and biomarker analysis. Safety and automation are becoming key trends in the market.
The Centers for Disease Control and Prevention (CDC) estimates that approximately 385,000 needlestick and sharps-related injuries occur annually among hospital healthcare workers in the United States, encouraging the adoption of safety-engineered needles and advanced collection systems. Additionally, the WHO highlights that laboratory testing influences nearly 70% of medical decisions, emphasizing the importance of reliable specimen collection. Growing healthcare investments, expansion of diagnostic laboratories, and increasing preventive screening programs are expected to support the continued growth of the blood collection devices market in the coming years.
Key Takeaways
- The global blood collection devices market is expected to reach approximately US$ 15.88 billion by 2034, growing from US$ 7.85 billion in 2024 at a CAGR of 7.3% during the forecast period.
- Needles and syringes dominated the product segment in 2024, accounting for more than 38.5% market share, supported by their widespread use in hospitals, diagnostic centers, and healthcare facilities.
- Manual blood collection methods held a leading position in 2024, capturing over 67.2% share of the method segment due to their cost-effectiveness and extensive adoption across healthcare settings.
- Diagnostic applications represented the largest application segment in 2024, contributing more than 65.3% market share, driven by increasing demand for blood-based testing and disease detection procedures.
- Diagnostic end-users accounted for the highest market share in 2024, exceeding 34.3%, due to the growing utilization of clinical laboratories for routine and specialized diagnostic testing.
- North America maintained its leading position in the global blood collection devices market in 2024, holding more than a 35.6% share and reaching an estimated market value of nearly US$ 2.79 billion.
Statistical Information
- Increasing Diabetes Cases Supporting Demand for Blood Collection Products: The rising global diabetes population is increasing the requirement for frequent blood glucose monitoring using lancets and blood sampling devices. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021. The number is projected to increase to 783 million adults by 2045, representing a growth of nearly 46% from 2021 levels.
- Growing Cancer Burden Increasing Blood-Based Diagnostic Procedures: Cancer diagnosis and monitoring require extensive laboratory testing, including blood-based biomarker analysis and routine blood examinations. The World Health Organization (WHO) reported approximately 20 million new cancer cases and 9.7 million cancer deaths globally in 2022. The number of cancer cases is expected to rise significantly, increasing the requirement for diagnostic procedures supported by blood collection devices.
- India’s Annual Blood Collection Volume Driving Blood Bag Demand: India has a significant requirement for blood collection products due to its large transfusion network. Government-linked reports indicate that India requires approximately 14.6 million blood units annually. During 2024–25, the country collected 14,601,147 blood units, compared with 12,695,363 units in 2023, representing an increase of around 15% year-on-year. Each collected unit requires sterile blood collection bags, donor needles, and sample collection materials.
- Increasing Blood Collection Volume Supporting Device Consumption: India’s blood collection volume increased by approximately 1.9 million units, rising from 12.69 million units in 2023 to 14.60 million units in 2024–25. This growth directly increases consumption of blood collection devices, including blood bags, donor collection needles, tubing systems, and testing sample tubes used during donation and processing procedures.
- Disease Burden Increasing Blood Testing and Collection Requirements: Clinical demand for blood products in India is influenced by anemia, maternal health conditions, trauma, surgery, cancer, and chronic diseases. Research indicates that approximately 45–50% of blood utilization is associated with anemia and obstetric cases, while around 15–20% is linked with trauma and surgical requirements. These conditions require extensive blood collection, testing, and monitoring procedures.
- Blood Unit Collection Creates Multiple Device Consumption Opportunities: Each whole blood donation generally requires multiple collection components, including one blood collection bag, sterile donor needle assembly, and multiple testing sample tubes. Based on India’s annual collection of approximately 14.6 million blood units, transfusion services may require an estimated 44–73 million collection-related disposable components annually, excluding diagnostic blood testing procedures.
- India’s Clinical Demand for Whole Blood Units Driving Collection Device Requirements: A national clinical modelling study estimated India’s annual requirement for whole blood at approximately 14.6 million units, with a 95% confidence interval of 14.59–14.62 million units. The requirement equals around 36.3 blood donations per 1,000 population, indicating a large recurring need for blood collection bags, donor needles, and related disposable devices.
- Expansion of Licensed Blood Banks Increasing Procurement Demand: According to Government of India data, the country had 4,153 licensed blood banks/blood centres as of November 30, 2023. The number increased significantly compared with 2,760 blood banks reported in 2015, demonstrating expansion of blood collection infrastructure and increasing requirements for blood bags, tubes, needles, and collection systems.
- Historical Growth in India’s Blood Collection Volume: Government statistics showed that India’s blood collection increased from approximately 9.94 million units in 2013–14 to 11.09 million units in 2016–17, representing growth of around 1.15 million units or nearly 12% during the period. The increase reflects expanding blood donation programs and growing demand for collection equipment.
- India Achieving Blood Collection Requirement Target in 2024–25: India collected approximately 14,601,147 blood units in 2024–25, exceeding the estimated annual requirement of 14.6 million units. Compared with 12,695,363 units collected in 2023, the volume increased by approximately 1.9 million units or 15%, supporting higher utilization of blood collection bags, donor sets, and testing tubes.
Regional Analysis
North America remained the leading regional market with over 35.6% share
North America maintained a leading position in the blood collection devices market in 2024, supported by advanced healthcare infrastructure, high diagnostic testing volumes, and strong healthcare expenditure. The United States healthcare system recorded US$4.9 trillion in national health expenditure in 2023, accounting for 17.6% of GDP, creating significant demand across hospitals, laboratories, and outpatient facilities.
The region’s high chronic disease burden continues to increase the need for blood-based diagnostics. According to the CDC, approximately 38.4 million Americans were living with diabetes, representing 11.6% of the U.S. population, requiring regular monitoring and laboratory testing. Cancer screening, preventive testing, and routine disease management further support the consumption of needles, tubes, lancets, and safety blood collection systems.
A mature clinical laboratory network and strict healthcare safety regulations also strengthen market adoption. Regulations promoting safer sharps technologies encourage hospitals and laboratories to adopt advanced blood collection devices designed to reduce occupational risks and improve patient safety.
Emerging Trends
- Growth of Safety-Engineered Blood Collection Devices: Healthcare facilities are increasingly adopting safety needles, retractable syringes, and closed blood collection systems to reduce needlestick injuries. The WHO highlights that safety-engineered devices can lower blood exposure risks. In the U.S., healthcare workers experience approximately 385,000 sharps injuries annually, increasing demand for safer collection technologies.
- Increasing Adoption of Vacuum Blood Collection Systems: Vacuum tube blood collection systems are gaining acceptance because they reduce direct blood exposure and allow multiple samples from a single venipuncture. WHO guidelines indicate that vacuum systems improve safety compared with traditional needle-and-syringe methods. These systems are increasingly used in hospitals and diagnostic laboratories requiring efficient sample handling.
- Expansion of Blood Safety Testing and Quality-Control Systems: Blood collection devices are evolving with stricter safety requirements for donor screening and transfusion practices. CDC reports that every blood donation undergoes testing for infectious markers, including HIV, hepatitis B, and hepatitis C. These requirements increase demand for standardized collection tubes, bags, and sampling devices.
- Rising Demand for Minimally Invasive and Capillary Blood Collection: Capillary blood collection devices using micro-needles and small-volume sampling are gaining importance for patient-friendly testing. FDA classifies capillary blood collection devices as medical devices used for collecting and transporting whole blood specimens for clinical analysis. These solutions support home monitoring and point-of-care diagnostics.
- Integration of Blood Collection with Advanced Diagnostic Workflows: Modern laboratories are focusing on improving sample accuracy, traceability, and contamination prevention. CDC emphasizes that proper blood collection practices are essential because inaccurate samples can delay diagnosis and treatment. Advanced collection devices are increasingly designed to support automated laboratory workflows and quality management systems.
Use Cases
- Hospital-Based Disease Diagnosis and Monitoring: Hospitals remain major users of blood collection devices for diagnosing infections, cancer, diabetes, and cardiovascular conditions. Blood samples support routine testing, emergency care, and treatment monitoring. CDC reports that blood safety programs require continuous screening and testing processes, creating consistent demand for collection consumables.
- Blood Banks and Transfusion Services: Blood collection bags, donor needles, and sample tubes are essential in blood banks for collection, processing, and safety testing. WHO monitors global blood systems across 168 countries, focusing on collection, testing, processing, and availability of safe blood products. This supports continued investment in collection infrastructure.
- Diabetes Self-Monitoring Applications: Blood collection devices such as lancets and capillary sampling tools are widely used for diabetes management. According to the CDC, approximately 38.4 million people in the United States have diabetes, requiring regular glucose monitoring and blood sampling. Growing self-testing practices support demand for convenient collection devices.
- Infectious Disease Screening Programs: Blood collection devices play a critical role in detecting infectious diseases through laboratory testing. CDC guidance indicates that donated blood is screened for multiple pathogens, including hepatitis viruses, HIV, and other infections. Increasing focus on transfusion safety and disease surveillance supports adoption of reliable collection systems.
- Research, Biotechnology, and Precision Medicine Applications: Blood samples are increasingly used in genetic testing, biomarker discovery, and personalized medicine research. FDA regulates blood specimen collection devices used for DNA testing and laboratory analysis. The growth of molecular diagnostics is creating demand for specialized collection tubes and specimen preservation technologies.
Frequently Asked Questions on Blood Collection Devices
- What factors are driving the growth of the blood collection devices market?
The market is driven by increasing diagnostic testing, rising chronic disease prevalence, expansion of healthcare facilities, and growing adoption of safer collection technologies. Increasing cases of diabetes, cancer, and infectious diseases are creating higher demand for blood sampling products. - Which product segment dominates the blood collection devices market?
Needles, syringes, and blood collection tubes are among the widely used product categories due to their applications in routine blood testing, emergency care, disease monitoring, and transfusion procedures. Their regular consumption supports continuous demand across healthcare settings. - How does chronic disease prevalence impact the blood collection devices market?
Chronic diseases such as diabetes, cancer, and cardiovascular disorders require frequent blood testing for diagnosis and treatment monitoring. The increasing global patient population is boosting demand for lancets, tubes, needles, and other blood collection products used in clinical procedures. - How are technological advancements affecting blood collection devices?
Innovations such as vacuum collection systems, micro-sampling technologies, and automated specimen handling are improving safety, accuracy, and patient comfort. These advanced solutions help laboratories reduce sample errors and enhance workflow efficiency during diagnostic testing procedures. - What are the major applications of blood collection devices?
Blood collection devices are used for disease diagnosis, blood donation, glucose monitoring, infectious disease screening, genetic testing, and clinical research. Hospitals, blood banks, diagnostic laboratories, and research centers rely on these devices for accurate sample collection. - How does blood donation contribute to market demand?
Blood donation activities increase demand for blood collection bags, donor needles, sample tubes, and sterile disposable equipment. Expansion of voluntary donation programs and blood bank infrastructure requires reliable collection products to support safe blood storage and transfusion services. - What is the future outlook for the blood collection devices market?
The market is expected to grow due to increasing diagnostic requirements, healthcare infrastructure expansion, and demand for minimally invasive collection methods. Rising focus on patient safety, infection prevention, and advanced laboratory technologies will continue driving future adoption. - What is the importance of blood collection devices in transfusion services?
Blood collection devices are essential for collecting, storing, and testing donated blood. Blood banks use sterile bags, needles, and sampling tubes to ensure safe collection and screening of blood components before transfusion to patients requiring emergency or therapeutic support.
Conclusion
The Blood Collection Devices Market is experiencing steady growth due to increasing diagnostic testing, rising chronic disease prevalence, expanding blood donation programs, and advancements in healthcare infrastructure. The growing demand for safe, accurate, and efficient blood sampling solutions is encouraging the adoption of safety-engineered needles, vacuum collection systems, and minimally invasive devices.
Hospitals, diagnostic laboratories, and blood banks remain key users, supported by rising disease screening and monitoring requirements. Technological innovation, infection prevention measures, and improved laboratory workflows will continue shaping market development. Overall, increasing healthcare needs and focus on patient and healthcare worker safety are expected to drive future market opportunities.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
